GLP-1 therapies, or glucagon-like peptide-1 analogs , represent a remarkable innovation in how we handle type 2 diabetes . These new therapies help imitating the body’s own GLP-1 substance , which https://bookmarkrange.com/story23606642/glp-1-a-major-approach-in-diabetes-management